News
LH-WI
207.45
0.00%
0.00
Labcorp Holdings Inc. Files Initial Beneficial Ownership Statement for Director Victor Bulto Carulla
Reuters · 12/03 12:32
CHS Sells Select Outreach Laboratory Assets to Labcorp for $194 Million
Reuters · 12/02 21:15
COMMUNITY HEALTH SYSTEMS COMPLETES SALE OF SELECT OUTREACH LABORATORY ASSETS TO LABCORP
Reuters · 12/02 21:15
Labcorp Appoints Novartis Executive Victor Bulto to Board of Directors
Reuters · 11/24 13:30
LABCORP APPOINTS VICTOR BULTO TO BOARD OF DIRECTORS
Reuters · 11/24 13:30
Labcorp Unveils Plasma Detect MRD Technology Advancing Cancer Detection and Treatment
Reuters · 11/19 12:05
LABCORP® PLASMA DETECT™ CLINICAL STUDIES FEATURED IN NATURE MEDICINE AND CLINICAL CANCER RESEARCH
Reuters · 11/19 12:05
Labcorp to Acquire Parkview Health Outreach Laboratory Assets
Reuters · 11/13 14:12
Labcorp Holdings CEO Adam H. Schechter Reports Disposal of Common Shares
Reuters · 11/13 13:48
U.S. RESEARCH ROUNDUP-DoorDash, Honeywell, Zscaler
Reuters · 11/10 07:58
LABCORP <LH.N>: PIPER SANDLER CUTS TARGET PRICE TO $270 FROM $280
Reuters · 11/10 05:39
U.S. RESEARCH ROUNDUP-Blackline, Carmax, Expedia
Reuters · 11/07 06:57
LABCORP <LH.N>: JP MORGAN RAISES TARGET PRICE TO $317 FROM $291
Reuters · 11/07 05:05
Labcorp Director Richelle P. Parham Reports Sale of Common Shares
Reuters · 11/04 15:29
Neogen Corporation Appoints Bryan Riggsbee as Chief Financial Officer
Reuters · 10/30 12:45
Healthcare firm OPKO's Q3 revenue falls 
Reuters · 10/29 20:37
LABCORP HOLDINGS INC <LH.N>: UBS CUTS TARGET PRICE TO $320 FROM $325
Reuters · 10/29 12:50
U.S. RESEARCH ROUNDUP-ATI, GoDaddy, Lyft
Reuters · 10/29 07:24
BUZZ -Labcorp falls after cutting growth outlook for research unit
Reuters · 10/28 17:50
LABCORP EXEC SAYS EXPECT EARLY-STAGE DRUG DEVELOPMENT BUSINESS TO GROW LOW-SINGLE DIGITS IN 2025 VS MID-SINGLE DIGITS EXPECTED EARLIER - CONF CALL
Reuters · 10/28 13:23
More
Webull provides a variety of real-time LH-WI stock news. You can receive the latest news about Laboratory Corp through multiple platforms. This information may help you make smarter investment decisions.
About LH-WI
Laboratory Corporation of America Holdings is a global life sciences company. The Company provides information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make decisions. The Company’s segments include Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). The Dx segment is an independent clinical laboratory business. It offers a menu of frequently requested and specialty diagnostic tests through an integrated network of primary and specialty laboratories across the United States. In addition to diagnostic testing along with occupational and wellness testing for employers and forensic DNA analysis, Dx segment also offers a range of other testing services. The DD segment is a contract research organizations business that provides end-to-end drug development services. The DD segment provides these services predominantly to pharmaceutical, biotechnology and medical device companies across the world. It serves clients in more than 100 countries.